BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35506912)

  • 1. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE; Uner A; Usubutun A
    Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
    [No Abstract]   [Full Text] [Related]  

  • 2. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
    J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
    Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
    Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
    Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L; Zhao W; Zhao Z; Zhu Y
    Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
    Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of
    Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
    Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
    Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
    Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
    Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
    Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
    Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
    In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
    Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
    Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
    Fong A; Offman S
    Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
    Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
    Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
    Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
    Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.